JPS6057837B2 - Method for producing cephalosporin compounds - Google Patents
Method for producing cephalosporin compoundsInfo
- Publication number
- JPS6057837B2 JPS6057837B2 JP14746775A JP14746775A JPS6057837B2 JP S6057837 B2 JPS6057837 B2 JP S6057837B2 JP 14746775 A JP14746775 A JP 14746775A JP 14746775 A JP14746775 A JP 14746775A JP S6057837 B2 JPS6057837 B2 JP S6057837B2
- Authority
- JP
- Japan
- Prior art keywords
- emu
- carboxylic acid
- acetoxymethyl
- reaction
- cephalosporin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
産業上の利用分野
本発明はセフアロスポリンCの同族体から酵素的にセフ
アロスポリン化合物を製造する方法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a process for the enzymatic production of cephalosporin compounds from cephalosporin C homologs.
従来の技術
ペルキー特許第736934号、英国特許第12727
69号、特開昭47−39595号、特開昭50−10
1584号に於いては、好気的条件下でアスペルギルス
属、ペニシリウム属、ノイロスポラ属、エアロバクター
属またはトリゴノプシス・バリアビリスから誘導”され
るD−アミノ酸オキシダーゼの利用例が知られている。Prior Art Pelkey Patent No. 736934, British Patent No. 12727
No. 69, JP-A-47-39595, JP-A-50-10
No. 1584 discloses the use of D-amino acid oxidase derived from Aspergillus, Penicillium, Neurospora, Aerobacter or Trigonopsis variabilis under aerobic conditions.
また英国特許第127276吟によれば、アジ化ナトリ
ウムを添加して3−アセトキシメチルー ー(4’一カ
ルボキシブタンアミド)セフー3−エムー4−カルボン
酸を生産する方法が明示されている。発明が解決しよう
とする問題点
セフアロスポリンc同族体の酵素による酸化的脱アミノ
反応は、優れた抗菌活性を有するセフアロスポリン誘導
体を開発製造する上て重要であるにもかかわらず、成功
例は少ない。British Patent No. 127276 discloses a method for producing 3-acetoxymethyl-(4'-carboxybutanamide)cefu-3-emu-4-carboxylic acid by adding sodium azide. Problems to be Solved by the Invention Although enzymatic oxidative deamination of cephalosporin c homologues is important for developing and producing cephalosporin derivatives having excellent antibacterial activity, there have been few success stories.
特に、D−α−アミノアジピン酸が酸アミド結合してい
るセフアロスポリンcの場合、普通のD−アミノ酸オキ
シダーゼでは作用しがたいことが問題となつている。ま
た、セフアロスポリンc同族体を単にDーアミノ酸オキ
シダーゼにより酵素的に酸化すると、3−アセトキシメ
チルー 7−(5’一カルボキシー5″−オキソペンタ
ンアミド)セフー3−エムー4−カルボン酸誘導体およ
び3−アセトキシメチルー7−(4″一カルボキシブタ
ンアミド)セフー3−エムー4−カルボン酸誘導体が得
られるが該誘導体を選択的に生産することができず、工
業的に不利であり、今だ充分ではない。問題を解決する
ための手段
本発明者らは、セフアロスポリンC醗酵プロスから7−
アミノセフアロスポラン酸類を製造するのに有利な中間
体3−アセトキシメチルー7一(5−カルボキシー5″
−オキソペンタンアミド)セフー3−エムー4−カルボ
ン酸または3−アセトキシメチルー7−(4″一カルボ
キシブタンアミド)セフー3−エムー4−カルボン酸が
、土壌中の検索微生物より分離した糸状菌Gk−340
nにより生成することを知つた。In particular, in the case of cephalosporin c, in which D-α-aminoadipic acid is bonded with an acid amide bond, there is a problem that ordinary D-amino acid oxidase is difficult to act on it. Furthermore, simply enzymatic oxidation of cephalosporin c homologues with D-amino acid oxidase results in the formation of 3-acetoxymethyl-7-(5'-carboxy5''-oxopentanamide)cefu-3-emu-4-carboxylic acid derivatives and 3- Although an acetoxymethyl-7-(4″-carboxybutanamide)cefu-3-emu-4-carboxylic acid derivative can be obtained, it is not possible to selectively produce the derivative, which is industrially disadvantageous, and is still insufficient. do not have. Means for Solving the Problem The inventors have devised a 7-
The advantageous intermediate 3-acetoxymethyl-7-(5-carboxy5'') for producing aminocephalosporanic acids
-Oxopentanamide) Cef 3-Emu 4-carboxylic acid or 3-acetoxymethyl-7-(4''-monocarboxybutanamide) Cef 3-Emu 4-carboxylic acid was isolated from the searched microorganism in soil, Gk -340
I learned that it is generated by n.
更に、鋭意研究した結果、本発明者らは、酵素と一般式
1の化合物との接触中に少量の過酸化水素水(35%)
を反応液に対して0.1〜0.5%添加することにより
、3−アセトキシメチルー7一(5−カルボキシー5″
−オキソペンタンアミド)セフー3−エムー4−カルボ
ン酸の生成を完全に押え、収量を減することなく3−ア
セトキシメチルー7−(4″一カルボキシブタンアミド
)セフー3−エムー4−カルボン酸を容易に、し々)も
、選択的に単離てきることを見い出し、本発明を完成し
た。Furthermore, as a result of intensive research, the present inventors discovered that a small amount of hydrogen peroxide (35%) was added during the contact between the enzyme and the compound of general formula 1.
By adding 0.1 to 0.5% of
-Oxopentanamide)Sefu 3-Emu 4-carboxylic acid production is completely suppressed, and 3-acetoxymethyl-7-(4''-carboxybutanamide)Sefu 3-Emu 4-carboxylic acid is produced without reducing the yield. The present invention has been completed based on the discovery that it is possible to easily and selectively isolate even the following.
作用
即ち、本発明はセフアロスポリンC醗酵プロスに含有す
る式
C
(式中、Rは水素原子、ヒドロキシル基、アセトキシル
基、または親核性残基を示す)で表わされる化合物又は
その塩を、醗酵プロスより抽出することなく、そのまま
D−アミノ酸オキシダーゼの生産能力を有する糸状菌G
k−34唯1微工研菌寄第3276号ョの培養物または
其の処理物を、水性媒体下で通気して接触させた後、ア
ジ化ナトリウム及び過酸化水素水の存在下で、カタラー
ゼ活性を阻害することにより式
(式中、Rは前記と同じ基を示す)で表わされるセフア
ロスポリン化合物または其の塩を選択的にの製造する方
法である。In other words, the present invention provides a method for adding a compound represented by the formula C (wherein R represents a hydrogen atom, a hydroxyl group, an acetoxyl group, or a nucleophilic residue) or a salt thereof contained in a cephalosporin C fermentation process to a fermentation process. Filamentous fungus G that has the ability to directly produce D-amino acid oxidase without further extraction.
After contacting the culture of K-34 1st Microtechnical Research Institute No. 3276 with aeration in an aqueous medium, catalase was added in the presence of sodium azide and hydrogen peroxide solution. This is a method for selectively producing a cephalosporin compound represented by the formula (wherein R represents the same group as above) or a salt thereof by inhibiting the activity.
上記糸状菌Gkml■株の各種培地上における培養の特
徴は、次に記載する通りである。The characteristics of culturing the above-mentioned filamentous fungus Gkml ■ strain on various media are as described below.
A肉眼的観察 1 ツアベツク寒天培地 生育は、やや早く3日間で直径3Tfaに達する。A: Macroscopic observation 1 Zavesk agar medium Growth is rather fast, reaching a diameter of 3 Tfa in 3 days.
菌糸は初め白色であるが、分生子が形成されるに従いオ
リーブ●イエロー(011veYe110w)となり、
更に長時間培養すると明るい黄味緑色(CObaltG
reen)となる。The hyphae are initially white, but as conidia are formed, they turn olive yellow (011veYe110w).
When cultured for an even longer period of time, the color becomes bright yellowish green (CObaltG).
reen).
分生子の形成は非常に多い。集落表面は綿毛状。裏面は
薄縁色(0pa11neGreen)〜赤紫色(Mag
enta)。Conidial formation is very common. The surface of the village is fluffy. The back side has a light edge color (0pa11neGreen) to reddish purple (Mag
enta).
拡散性色素は生成しない。2麦芽汁寒天培地
生育はツアベツク寒天培地より菌糸の伸長が抑制的て遅
く3日間で直径2wnである。No diffusible dye is produced. 2 Growth on wort agar medium was slower than on Zawbek agar medium as hyphae elongation was suppressed and grew to 2wn in diameter in 3 days.
培養初期は白色であるが、分生子が形成されるに従い草
色(GrassGreen)となる。分生子は早期に形
成され非常に多い。集落表面はビロード状。裏面は薄黄
色(Cream)〜赤紫色(Magenta)。拡散性
色素は生成しない。3 オートミール寒天培地
生育は早く拡大性、3日間で41!Rmに達する。The color is white at the initial stage of culture, but becomes grass green as conidia are formed. Conidia are formed early and are very numerous. The surface of the village is velvety. The back side is light yellow (Cream) to reddish purple (Magenta). No diffusible dye is produced. 3 Growth on oatmeal agar medium is fast and expandable, 41 cells in 3 days! Reach Rm.
菌糸は初め白色であるが、分生子が形成され暗緑色(F
OrestGreen)となり表面に水滴を生ずる。分
生子は多い。集落表面はビロード状。裏面は薄黄色(P
aleYellOw)である。B顕微鏡的観察
分生子柄は非対象に分枝しその長さは30〜70μ、基
部の巾は1.9μであるが一般的には巾3μ壁は平滑で
やや厚い。The hyphae are initially white, but as conidia form, they turn dark green (F
Orest Green) and water droplets are formed on the surface. There are many conidia. The surface of the village is velvety. The back side is light yellow (P
aleYellOw). B. Microscopic Observation The conidiophores are asymmetrically branched and have a length of 30 to 70 μm and a width of 1.9 μm at the base, but the walls are generally 3 μm wide and smooth and somewhat thick.
基底分枝(Branchesraml)はなく、分生子
柄に接続する基底担子(Hetulae)7×0.7μ
が分枝する。その上にペン先型フイアライドが群生し、
夫々惰円型1.5μ〜1.8μ×21μの分生子が連鎖
する。分生子連鎖はオートミール寒天培地で約1帽、ツ
アベツク寒天培地で約1陥、麦芽汁寒天培地で約20〜
3陥である。これらの連鎖した分生子は密生して扇状の
大集塊を呈する。閉子のう穀、菌核は認められない。C
生育条件
生育温度は15〜40℃、生育PHは3.0〜7.へ最
適生育温度は28〜377C1最適生育PHは4.0〜
5.0である。No basal branches (Branchesraml), basal basidia (Hetulae) 7 x 0.7μ connected to conidiophores
branches out. On top of that, pen-tip-shaped firerides grow in clusters,
Conidia each having a circular shape of 1.5 μ to 1.8 μ×21 μ are linked together. The number of conidial chains is about 1 cap on oatmeal agar, about 1 cap on Zavesk agar, and about 20 to 20 on wort agar.
There are 3 pitfalls. These chained conidia grow densely and form large fan-shaped agglomerates. No cleistocysts or sclerotia are observed. C
Growth conditions Growth temperature is 15-40°C, growth pH is 3.0-7. Optimum growth temperature is 28-377C1 Optimum growth pH is 4.0-
It is 5.0.
上記の菌学的性状を有する糸状菌Gk−340菌株の分
類学上の位置をギルマンズ ア マニュアルオブ ソイ
ル フアンジ(J.C.Gilman″SAManua
lOfSOilFungi)、レイパー、トム共著のア
マニアル オブ ザ ペニシリア(AManualO
fTllePeniciIlla)およびパーネットの
インパーフエクト フアンジ(111ustrated
Ger1era0fImperfectfur1gi)
を参照して検討し、さらに本菌株の近縁と認められるI
FO−6617と比較検討した結果、本菌株は肉眼では
ペニシリウムのような外観であるが顕微鏡で分生子構造
を観察し、グリオクラデイウム属(GIiOcladi
um)に属するものと判定される。The taxonomic position of the filamentous fungus Gk-340 strain having the above mycological properties was determined by J.C. Gilman''SA Manua.
A Manual of the Penicilia (1OfSOilFungi), Raper, Tom (co-authored)
fTllePeniciIlla) and Parnett's Imperfect Juange (111ustrated
Ger1era0fImperfectfur1gi)
I, which is considered to be a close relative of this strain,
As a result of comparative study with FO-6617, this strain has a penicillium-like appearance to the naked eye, but its conidial structure was observed under a microscope, and it was found to be a member of the genus Gliocladium (GIiOcladium).
um).
なお、本菌株は工業技術院微生物工業研究所に1微工研
菌寄第3276号ョとして寄託されている。This strain has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology as No. 3276.
酵素生産菌株を培養するに当つては、炭素源としてグル
コース、澱粉、窒素源として落花生粉、綿実粕、無機塩
として燐酸カリ、硫酸マグネシウムなどの他、D−α−
アミノアジピン酸側鎖のオキシダーゼを誘導するためD
−アミノ酸が必要である。D−グルタミン酸を用いる場
合、添加量0.1〜3%ではオキシダーゼ生成に著しく
影響し、添加増量が生成量に比例する知見を得た。DL
−グルタミン酸でも有効であるが、D−グルタミン酸と
して0.3%以上含有していることが望ましい。28℃
で約2m間の通気攪拌培養を行う。In culturing enzyme-producing bacterial strains, in addition to glucose and starch as carbon sources, peanut flour and cottonseed meal as nitrogen sources, potassium phosphate and magnesium sulfate as inorganic salts, D-α-
D to induce aminoadipic acid side chain oxidase
- Amino acids are required. When D-glutamic acid is used, it has been found that an addition amount of 0.1 to 3% significantly affects oxidase production, and that an increase in the addition amount is proportional to the production amount. DL
-Glutamic acid is also effective, but it is desirable to contain 0.3% or more of D-glutamic acid. 28℃
Culture with aeration for approximately 2 m.
このような誘導培養により蓄積した著量のオキシダーゼ
含有菌体は濾別したままでも使用できるが、更に菌体を
凍結融解するか又は生菌体をアーカードCなどと接触(
対液0.1%で1時間)させることにより酵素の活性化
を一層促進させることができる。セフアロスポリンC培
養プロスに適用して反応させる場合、D−α−アミノア
ジピン酸側鎖オキシダーゼの浪費を防ぐため、セフアロ
スポリンC培養プロスの濾過液を弱酸性カチオン交換樹
脂たとえばアンパーライトIRC−50(Na+)で前
処理(PH6.Oの酸性液として通過)することが好ま
しい。A significant amount of oxidase-containing microbial cells accumulated through such induction culture can be used even after being filtered, but the microbial cells should be further frozen and thawed or the live microbial cells should be brought into contact with Alucard C etc. (
Enzyme activation can be further promoted by incubating at 0.1% solution for 1 hour). When applying and reacting with Cephalosporin C culture process, in order to prevent waste of D-α-aminoadipic acid side chain oxidase, the filtrate of Cephalosporin C culture process is mixed with a weakly acidic cation exchange resin such as Amperlite IRC-50 (Na+). Pretreatment (passed as an acidic liquid with pH 6.0) is preferable.
この前処理液にGK−34話性化菌体を6〜10%添加
し、PH7.O〜7.5に修正後、反応温度33′Cl
l〜5v.v.m.の通気下10r.p.m.以上の高
速攪拌で2〜3時間反応させる。以上の活性化技術およ
びイオン交換樹脂による前処理を組み合わせて酵素反応
を行うと、全く酵素阻害を受けることなく、・セフアロ
スポリンC培養プロスから高収率で目的物が得られる。
実際には既にべたように、D−アミノ酸オキシダーゼ活
性化菌体と一般式1の化合物を接触させる際、2つの化
合物すなわち3−アセトキシメチルー7−(5″一カル
ボキシー5″−オキソペンタンアミド)セフー3−エム
ー4−カルボン酸および3−アセトキシメチルー7−(
4―カルボキシブタンアミド)セフー3−エムー4ーカ
ルボン酸が生産される。この際、アジ化ナトリウム及び
過酸化水素水を用いて、カタラーゼ活性を阻害すると、
3−アセトキシメチルー7一(4″一カルボキシブタン
アミド)セフー3−エムー4−カルボン酸が選択的に生
産される。即ち、3−アセトキシメチルー7−(4−カ
ルボキシブタンアミ(へ)セフニ3−エムー4−カルボ
ン酸を生産する場合には、酸化反応中0.1〜0.2%
のアジ化ナトリウムを添加し、更に反応中3紛後に35
%過酸化水素水0.25%を加え、6紛後さらに0.1
5%を加える。6 to 10% of GK-34 cells were added to this pretreatment solution, and the pH was adjusted to 7. After adjusting the temperature to 0~7.5, the reaction temperature was 33'Cl
l~5v. v. m. ventilation under 10r. p. m. The reaction is allowed to proceed for 2 to 3 hours with the above high-speed stirring. When an enzymatic reaction is performed by combining the above activation technique and pretreatment with an ion exchange resin, the desired product can be obtained in high yield from the cephalosporin C culture process without any enzyme inhibition.
In fact, as mentioned above, when D-amino acid oxidase-activated bacterial cells are brought into contact with the compound of general formula 1, two compounds, namely 3-acetoxymethyl-7-(5''-carboxy-5''-oxopentanamide) are produced. Cefu 3-emu 4-carboxylic acid and 3-acetoxymethyl-7-(
4-carboxybutanamide) cef 3-emu 4-carboxylic acid is produced. At this time, if sodium azide and hydrogen peroxide are used to inhibit catalase activity,
3-acetoxymethyl-7-(4'-carboxybutanamido)cef-3-emu-4-carboxylic acid is selectively produced. When producing 3-emu-4-carboxylic acid, 0.1 to 0.2% during the oxidation reaction.
of sodium azide was added, and after 3 minutes during the reaction, 35
Add 0.25% hydrogen peroxide solution, and after 6 powders add 0.1% hydrogen peroxide solution.
Add 5%.
生成した3−アセトキシメチルー7−(4″一カルボキ
シブタンアミド)セフー3−エムー4−カルボン酸の量
は、酢酸エチルなどの有機溶媒で抽出した後、そのW吸
収(260r1m)を測定して定量する。The amount of 3-acetoxymethyl-7-(4″-carboxybutanamide)cefu-3-emu-4-carboxylic acid produced can be determined by measuring its W absorption (260r1m) after extraction with an organic solvent such as ethyl acetate. Quantify.
また同時に薄層クロマトグラフィ(展開溶媒イソプロパ
ノールニ水=7:3)によつても反応完結を確認する。
酸化反応後、反応液のPHを6.0以下にし濾過する。
反応濾液は、そのまま若しくは濃縮しPHを1.5〜2
.0に修正した後、水と混和しない有機溶媒たとえばメ
チルイソブチルケトン、n−ブタノール、酢酸エチルな
どで抽出を行う。若し必要なら反応液は、次の濃縮操作
を加えてもよい。即ち反応濾液を、その15%量の強塩
基性陰イオン交換樹脂(例えばPA−30巳1RA−4
01など)の酢酸タイプに吸着させ、樹脂の1.5〜2
倍量の水で洗浄後、0.2〜1.CM塩化アンモニウム
溶液で溶出する。溶出液は減圧下で濃縮し、反応液の1
110〜1112とする。この濃縮液は、PHl.5〜
2.1とし、水と混和しない同量の有機溶媒て3回抽出
し、その有機溶媒を減圧下て溜去することにより、3−
アセトキシメチルー7−(4″一カルボキシブタンアミ
ド)セフー3−エムー4−カルボン酸の粗粉末を得る。At the same time, completion of the reaction is also confirmed by thin layer chromatography (developing solvent: isopropanol/water = 7:3).
After the oxidation reaction, the pH of the reaction solution is lowered to 6.0 or less and filtered.
The reaction filtrate can be used as it is or concentrated to have a pH of 1.5 to 2.
.. After adjusting to 0, extraction is performed with an organic solvent that is immiscible with water, such as methyl isobutyl ketone, n-butanol, ethyl acetate, etc. If necessary, the reaction solution may be subjected to the following concentration operation. That is, the reaction filtrate was treated with 15% of the strongly basic anion exchange resin (for example, PA-30-1RA-4).
01 etc.) and adsorb it to an acetic acid type of resin (1.5~2).
After washing with twice the amount of water, 0.2 to 1. Elute with CM ammonium chloride solution. The eluate was concentrated under reduced pressure, and 1 of the reaction solution was
110 to 1112. This concentrate is PHL. 5~
2.1 and extracted three times with the same amount of an organic solvent that is immiscible with water, and the organic solvent was distilled off under reduced pressure to obtain 3-
A crude powder of acetoxymethyl-7-(4″-carboxybutanamide)cefu-3-emu-4-carboxylic acid is obtained.
溶媒抽出時に食塩などの塩を添加することは、溶媒抽出
を完全に行う上で好ましい方法の一つである。粗粉末を
精製するには、3倍容のメタノールを加え完全に溶解後
、30〜40f8量のエーテルを加えることにより不純
物を沈澱させる。Adding salt such as common salt during solvent extraction is one of the preferred methods for completely performing solvent extraction. To purify the crude powder, add 3 times the volume of methanol to completely dissolve it, and then add 30 to 40 f8 amounts of ether to precipitate impurities.
そのエーテル層は濾過後に濃縮すると、針状結晶が析出
するので、濾別してから改めてクロロホルムで洗浄し減
圧乾燥させる。もしくは、粗粉末を等量のメチルイソブ
チルケトンに溶解し、ナトリウムー2−エチルヘキサノ
エートを添加することによつてもナトリウム塩として析
出させることができる。When the ether layer is concentrated after filtration, needle-shaped crystals are precipitated, so after the ether layer is filtered off, it is washed again with chloroform and dried under reduced pressure. Alternatively, the sodium salt can be precipitated by dissolving the crude powder in an equal amount of methyl isobutyl ketone and adding sodium-2-ethylhexanoate.
反応溶液から有機溶媒で抽出した3−アセトキシメチル
ー7−(4″一カルボキシブタンアミド)セフー3−エ
ムー4−カルボン酸は、有機溶媒を全量溜去することな
く単に113〜114に濃縮した後ジシクロヘキシルア
ミンを添加し夫々の塩として沈澱分別することもできる
。3-acetoxymethyl-7-(4″-carboxybutanamide)cefu-3-emu-4-carboxylic acid extracted from the reaction solution with an organic solvent was simply concentrated to 113 to 114 without distilling off the entire amount of the organic solvent. It is also possible to add dicyclohexylamine and precipitate and separate the respective salts.
次に実施例を挙けて本発明を具体的に説明するが、これ
により本発明を限定するものではない。EXAMPLES Next, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto.
実施例1グリオクラデイウム・GK−34唯を合同フラ
ワー4%、ピーナツミール1.5%、第1燐酸カリ0.
2%、硫酸マグネシウム0.05%を含む前培養液体培
地60m1に接種し28゜Cで24〜48時間振盪培養
した後、グルコース4%、ピーナツミール1.5%、D
−グルタミン酸0.5%、第1燐酸カリ0.2%、硫酸
マグネシウム0.05%を含むシート培地250m1に
移液し詔時間28′Cで振盪培養する。Example 1 Gliocladium GK-34 Yui was mixed with 4% joint flour, 1.5% peanut meal, and 0.0% monobasic potassium phosphate.
After inoculating 60 ml of a preculture liquid medium containing 2% magnesium sulfate, 0.05% magnesium sulfate, and culturing with shaking at 28°C for 24 to 48 hours, it was incubated with glucose 4%, peanut meal 1.5%, D
- Transfer to 250 ml of sheet medium containing 0.5% glutamic acid, 0.2% monobasic phosphate, and 0.05% magnesium sulfate, and culture with shaking at 28'C.
このシート1eをグルコース4%、ピーナツミール2%
、DL−グルタミン酸0.5%、第1燐酸カリ0.1%
、硫酸マグネシウム0.05%を含むタンク培地130
1に移液し、2g′Cで約n時間通気攪拌培養するが培
養停止時期はプロスPHが5.0まで上昇した時点とす
る。この際アーガードCを130m1加え1時間攪拌後
、フィルターブレスで濾過水洗しD−アミノ酸オキシダ
ーゼの活性化湿菌体8k9が得られた。これを一20℃
で凍結保存した。一方、セフアロスポリンC培養プロス
は濾過し、その濾液601(セフアロスポリンCとして
216′を含む)2N−NaOHでPH6.Oに修正し
、アンパーライト1RC−50(Naつ6jにSV=3
で通過させる。This sheet 1e contains 4% glucose and 2% peanut meal.
, DL-glutamic acid 0.5%, monopotassium phosphate 0.1%
, tank medium 130 containing 0.05% magnesium sulfate
1 and cultured at 2 g'C with aeration for about n hours, but the culture was stopped when the pH of the prosthesis rose to 5.0. At this time, 130 ml of Argard C was added and after stirring for 1 hour, the mixture was filtered and washed with water using a filter breath to obtain 8k9 wet bacterial cells with activated D-amino acid oxidase. This is -20℃
It was stored frozen. On the other hand, the cephalosporin C culture process was filtered, and the filtrate 601 (containing 216' as cephalosporin C) was diluted with 2N-NaOH to pH 6. Corrected to O, Amperlite 1RC-50 (SV = 3
Let it pass.
通過液は直ちに心−HCI″C′PH5.5〜6.0に
修正する。酸化反応をする際には、このIRC−50の
処理液60e(セフアロスポリンCとして205.2V
を含む)2N−NaOH′C−PH7.5に修正し通気
攪拌装置を備えたタンクに入れ温度を33′Cとした後
アジ化ナトリウム90fを添加し、更に前記の活湿菌体
5k9を加え3v.v.m.の通気下200r.p.m
.で攪拌する。Immediately correct the pH of the passed-through liquid to 5.5 to 6.0. When carrying out the oxidation reaction, use this IRC-50 treatment liquid 60e (205.2V as cephalosporin C).
After adjusting the pH to 2N-NaOH'C-PH7.5 and bringing the temperature to 33'C in a tank equipped with an aeration stirring device, 90f of sodium azide was added, and 5k9 of the live wet bacterial cells were added. 3v. v. m. under ventilation of 200r. p. m
.. Stir with.
反応開始後、初めの約2紛間までPHが低下するのでP
H7.O〜&0に維持した。3紛後に35%過酸化水素
水150m1を加え、更に6紛後にも100m1加える
。After the reaction starts, the pH decreases until about the first 2 minutes, so P
H7. It was maintained at O~&0. After the third powder, add 150 ml of 35% hydrogen peroxide solution, and after the sixth powder, add 100 ml.
反応中30分毎に薄層クロマトグラフィ定性的検出(展
開溶媒はイソプロパノールニ水=7:3)を行う。また
1時間毎に試料1m1を採りPH2.Oに修正し酢酸エ
チル8m1を加えて5分間振盪し、その酢酸エチル層か
ら5m1を分取して0.4M一NaHCO3溶液5m1
を加えさらに5分間振盪後、水層の260r1mの吸収
を測定し、3−アセトキシメチルー7−(4″一カルボ
キシブタンアミド)セフー3−エムー4−カルボン酸の
生成量を測定した。その結果、反応1時間後に1400
r′/ml、2時間目には2500r/mlとなつた。
酸化反応は約2時間て終り、反応液はPH6.Oに・修
正後、濾過助剤1kgを加えてフィルターブレスて濾過
し、濾液7.8eを得た。Qualitative thin layer chromatography detection (developing solvent is isopropanol/water = 7:3) is performed every 30 minutes during the reaction. In addition, 1 ml of sample was taken every hour and the pH was 2. O, add 8 ml of ethyl acetate, shake for 5 minutes, separate 5 ml from the ethyl acetate layer, and add 5 ml of 0.4M NaHCO3 solution.
After further shaking for 5 minutes, the absorption of the aqueous layer at 260r1m was measured, and the amount of 3-acetoxymethyl-7-(4''-carboxybutanamide)cefu-3-emu-4-carboxylic acid produced was measured.The results , 1400 after 1 hour of reaction
r'/ml, which reached 2500 r/ml in the second hour.
The oxidation reaction was completed in about 2 hours, and the reaction solution had a pH of 6. After adjusting to O, 1 kg of filter aid was added and filtered using a filter breath to obtain filtrate 7.8e.
この濾液を高速液体クルマトグラフイーで測定すると、
3−アセトキシメチルー7−(4″一カルボキシブタン
アミド)セフー3−エムー4−カルボン酸146yが生
.産されていると推定された。この反応濾液をPH6.
Oに修正後アンパーライトIRA−401(CH3CO
O−)91SV=3で通過させ、水13.5eで洗浄し
た。その際、吸着廃液と水洗液には未反応のセフアロス
ポリンC47.8yが、ヒドロキシルアノミン法により
測定された。前述のIRA−401樹脂は、0.2M−
NH4Cl4.5elO.5M−NH4Cll3.5e
..IM−NH,Cl25eでステツプワイズに溶出し
、活性フラクシヨンを18eを得た。When this filtrate is measured using high-speed liquid chromatography,
It was estimated that 146y of 3-acetoxymethyl-7-(4''-carboxybutanamide)cefu-3-emu-4-carboxylic acid was produced.The reaction filtrate was diluted to pH 6.
Amperlite IRA-401 (CH3CO
O-)91SV=3 and washed with 13.5e of water. At that time, unreacted cephalosporin C47.8y was measured in the adsorption waste liquid and washing liquid by the hydroxylanomine method. The aforementioned IRA-401 resin is 0.2M-
NH4Cl4.5elO. 5M-NH4Cll3.5e
.. .. The active fraction 18e was obtained by stepwise elution with IM-NH, Cl25e.
この活性フラクシヨンを1部採取し酢酸エチル抽出重曹
転溶液の260r1m吸収測定値は、102fであつた
。この活性フラクシヨンをn−ブタノール5eと共沸さ
せ5eまで濃縮後、食塩、1.5k9を加え濃塩酸でP
Hl.8とした後、メチルイソブチルケトン51′で3
回抽出した。A portion of this active fraction was collected, extracted with ethyl acetate, and the sodium bicarbonate inversion solution had an absorption measurement value of 102 f at 260 r1m. This active fraction was azeotroped with n-butanol 5e and concentrated to 5e, then added with 1.5k9 of common salt and purified with concentrated hydrochloric acid.
Hl. 8, and then 3 with methyl isobutyl ketone 51'.
Extracted twice.
この抽出液を減圧下で完全に溜去し93Vの3−アセト
キシメチルー7−(4″一カルボキシブタンアミド)セ
フー3−エムー4−カルボン酸の粗粉末が得られた。実
施例2
実施例1と同じ方法で調製した3−アセトキシメチルー
7−(4″一カルボキシブタンアミド)セフー3−エム
ー4−カルボン酸の粗粉末を精製するには上記の粗粉末
120yにメタノール360m1を加えて溶解後さらに
エーテル3.6eを加え、生じた沈澱を濾過し、濾液を
減圧下で100m1まで濃縮すると針状結晶を生じた。This extract was completely distilled under reduced pressure to obtain a crude powder of 93V of 3-acetoxymethyl-7-(4''-carboxybutanamide)cefu-3-emu-4-carboxylic acid.Example 2 To purify the crude powder of 3-acetoxymethyl-7-(4″-carboxybutanamide)cefu 3-emu-4-carboxylic acid prepared by the same method as in 1, add 360 ml of methanol to 120 y of the above crude powder and dissolve it. Afterwards, 3.6e of ether was further added, the resulting precipitate was filtered, and the filtrate was concentrated under reduced pressure to 100 ml to yield needle-like crystals.
この結晶を濾過し、クロロホルム200m1で洗浄後、
減圧乾燥し3−アセトキシメチルー7−(4″一カルボ
キシブタンアミド)セフー3−エムー4−カルボン酸の
結晶82yを得た。このもののノ元素分析値はCl5H
8N2O8Sとして、次の通りであつた。実施例3
セフアロスポリンCの培養濾液から実施例1と同じ方法
で阻害物質をアンパーライトIRC−50(Na+)で
除去した前処理液6e(セフアロスポリンCを18.3
Vを含む)とD−アミノ酸オキシダーゼ活性化菌体50
0yとアジ化ナトリウム9yを通気下33℃で2時間反
応させる。After filtering the crystals and washing with 200 ml of chloroform,
Drying under reduced pressure gave crystals 82y of 3-acetoxymethyl-7-(4''-carboxybutanamide)cefu-3-emu-4-carboxylic acid.The elemental analysis value of this was Cl5H.
8N2O8S was as follows. Example 3 Inhibitors were removed from the culture filtrate of Cephalosporin C using Amperlite IRC-50 (Na+) in the same manner as in Example 1.
containing V) and D-amino acid oxidase activated bacterial cells 50
0y and sodium azide 9y are reacted at 33° C. for 2 hours under ventilation.
その反応時間中先づ反応開始3吟後に35%過酸化水素
水15m1を加え、更に6紛後に10m1を追加した。
目的物の生成量は12.4yの測定値であつた。この反
応終了液を30%硫酸でPHl.8に修正して濾過し濾
液6.3eを得た。During the reaction time, 15 ml of 35% hydrogen peroxide solution was added after 3 minutes from the start of the reaction, and 10 ml was added after 6 minutes.
The amount of the target product produced was a measured value of 12.4y. This reaction-completed solution was added with 30% sulfuric acid to PHL. 8 and filtered to obtain filtrate 6.3e.
この濾液を5℃に冷却し、等量のメチルイソブチルケト
ンで3回くり返し抽出して溶媒層6.3eを集めた。こ
れを1.96eまで濃縮し、活性炭0.6yを加えて2
紛間攪拌後濾過する。The filtrate was cooled to 5° C. and extracted three times with an equal volume of methyl isobutyl ketone to collect the solvent layer 6.3e. Concentrate this to 1.96e, add 0.6y of activated carbon, and
After stirring, filter.
この濾液および改めてメチルイソブチルケトン100m
1を用いた活性炭洗一浄濾液を集める。このメチルイソ
ブチルケトン液にジシクロヘキシルアミン7.8m1を
加え、10℃で9紛攪拌し沈澱を濾過する。この沈澱は
、先づメチルイソブチルケトン900m1で洗浄し、次
いでアセトン1eで再洗浄後、乾一燥し、3−アセトキ
シメチルー7−(4″一カルボキシブタンアミド)セフ
ー3−エムー4−カルボン酸のジシクロヘキシルアミン
塩16.1yを得た。This filtrate and 100 m of methyl isobutyl ketone
Collect the filtrate after washing with activated carbon using 1. 7.8 ml of dicyclohexylamine was added to this methyl isobutyl ketone solution, stirred at 10°C, and the precipitate was filtered. This precipitate was first washed with 900 ml of methyl isobutyl ketone, then washed again with acetone 1e and dried to form 3-acetoxymethyl-7-(4''-carboxybutanamide)cefu 3-emu 4-carboxylic acid. 16.1y of the dicyclohexylamine salt was obtained.
実施例4実施例1と同じ方法て調製した3−アセトキシ
・メチルー7−(4″一カルボキシブタンアミド)セフ
ー3−エムー4−カルボン酸の粗粉末20yを200m
1の酢酸エチルに溶解し、濾過して不溶物質を除去し1
13〜11諸に濃縮した後〔ナトリウムー2−エチルヘ
キサノエート(4).05M)7.6y/酢酸エチル2
2m1〕の溶液を攪拌しつつ添加すると黄色のナトリウ
ム塩を析出する。Example 4 20y of crude powder of 3-acetoxy methyl-7-(4″-carboxybutanamide)cefu 3-emu-4-carboxylic acid prepared in the same manner as in Example 1 was added to 200 m
Dissolve 1 in ethyl acetate and filter to remove insoluble materials.
After concentrating to 13 to 11 [sodium-2-ethylhexanoate (4). 05M) 7.6y/ethyl acetate 2
2 ml] of the solution was added with stirring to precipitate a yellow sodium salt.
これを酢酸エチル(約30m1)で2回洗浄して乾燥し
、3−アセトキシメチルー7−(4″一カルボキシブタ
ンアミド)セフー3−エムー4−カルボン酸のナトリウ
ム塩結晶16yを得た。参考例1
D−アミノ酸オキシダーゼ活性を有する乾燥菌体粉末4
5fIを、アンパーライトIRC−50Naで前処理し
たセフアロスポリンCプロス1.5′に加え、更にアジ
化ナトリウム700m9を追加してPH8.Oとし毎分
2V′/vの通気量下33℃で攪拌しながら反応させた
。This was washed twice with ethyl acetate (approximately 30 ml) and dried to obtain sodium salt crystals 16y of 3-acetoxymethyl-7-(4''-carboxybutanamide)cefu-3-emu-4-carboxylic acid.Reference Example 1 Dry bacterial cell powder 4 having D-amino acid oxidase activity
5fI was added to Cephalosporin C Pros 1.5' pretreated with Amperlite IRC-50Na, and 700 m9 of sodium azide was added to adjust the pH to 8. The reaction was carried out at 33° C. with stirring at an air flow rate of 2 V′/v per minute.
反応は5時間で完了し、3−アセトキシメチルー(5″
一カルボキシー5″−オキソペンタンアミド)セフー3
−エムー4−カルボン酸は反応開始後1時間で一定量に
達し、それ以上には増加しなかつた。最終的には、セフ
アロスポリンCの26.2%が3−アセトキシメチルー
(5″一カルボキシー5″−オキソペンタンアミド)セ
フー3一エムー4−カルボン酸に転換し、54.2%相
当が3−アセトキシメチルー7 −(4’一カルボキシ
ブタンアミド)セフー3−エムー4−カルボン酸に変換
した。発明の効果
本発明の製造法によれば、セフアロスポリンc同族体に
D−アミノ酸オキシダーゼの生産能力を有するグリオク
ラデイウム(GliOcladium)属に属する微生
物の培養物又はその処理物を水性媒体下で通気して接触
させ、カタラーゼ活性を阻害することにより、7−アミ
ノセフアロスポラン酸誘導体の有用な中間体である3−
アセトキシメチルー7 −(4’一カルボキシブタンア
ミド)セフー3−エムー4−カルボン酸誘導体が選択的
に容易に得られる。The reaction was completed in 5 hours and 3-acetoxymethyl (5″
-carboxy5″-oxopentanamide) Cefu 3
-Emu-4-carboxylic acid reached a certain amount one hour after the start of the reaction and did not increase any further. Finally, 26.2% of cephalosporin C was converted to 3-acetoxymethyl-(5''-carboxy5''-oxopentanamide)cefu-3-emu-4-carboxylic acid, and the equivalent of 54.2% was converted to 3- It was converted to acetoxymethyl-7-(4'-carboxybutanamide)cefu-3-emu-4-carboxylic acid. Effects of the Invention According to the production method of the present invention, a culture of a microorganism belonging to the genus GliOcladium, which has the ability to produce D-amino acid oxidase in a cephalosporin c homolog, or a treated product thereof is aerated in an aqueous medium. 3-aminocephalosporanic acid derivatives are useful intermediates for 7-aminocephalosporanic acid derivatives by contacting them with
Acetoxymethyl-7-(4'-monocarboxybutanamide)cefu-3-emu-4-carboxylic acid derivatives can be easily obtained selectively.
Claims (1)
基、または親核性残基を示す)で表わされる化合物又は
其の塩を、醗酵ブロスより抽出することなく、そのまま
D−アミノ酸オキシダーゼの生産能力を有するグリオク
ラデイウム(Gliocladium)属に属する微生
物の培養物または其の処理物を、水性媒体下で通気して
接触させた後、アジ化ナトリウム及び過酸化水素水の存
在下で、カタラーゼ活性を阻害することを特徴とする式
▲数式、化学式、表等があります▼ (II) (Rは前記と同じ基を示す)で表わされるセフアロスポ
リン化合物または其の塩の製造法。[Claims] A compound represented by the formula ▲ Numerical formula, chemical formula, table, etc. ▼ (I) (wherein R represents a hydrogen atom, a hydroxyl group, an acetoxyl group, or a nucleophilic residue) or Without extracting the salt from the fermentation broth, a culture of a microorganism belonging to the genus Gliocladium that has the ability to produce D-amino acid oxidase or a processed product thereof is aerated in an aqueous medium. Formulas that are characterized by inhibiting catalase activity in the presence of sodium azide and hydrogen peroxide after contact ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (II) (R is the same group as above) A method for producing a cephalosporin compound or a salt thereof represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14746775A JPS6057837B2 (en) | 1975-12-12 | 1975-12-12 | Method for producing cephalosporin compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14746775A JPS6057837B2 (en) | 1975-12-12 | 1975-12-12 | Method for producing cephalosporin compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5272886A JPS5272886A (en) | 1977-06-17 |
JPS6057837B2 true JPS6057837B2 (en) | 1985-12-17 |
Family
ID=15431027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14746775A Expired JPS6057837B2 (en) | 1975-12-12 | 1975-12-12 | Method for producing cephalosporin compounds |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6057837B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0431623Y2 (en) * | 1985-05-14 | 1992-07-29 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5915635B2 (en) * | 1976-04-09 | 1984-04-10 | 東洋醸造株式会社 | Method for producing 7-(4-carboxybutanamide)-3-cephem-4-carboxylic acid compound |
KR100643148B1 (en) * | 2003-05-16 | 2006-11-10 | 종근당바이오 주식회사 | 7-Glutaryl imide cephalosporanic acid derivatives and process for preparing it |
-
1975
- 1975-12-12 JP JP14746775A patent/JPS6057837B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0431623Y2 (en) * | 1985-05-14 | 1992-07-29 |
Also Published As
Publication number | Publication date |
---|---|
JPS5272886A (en) | 1977-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4774179A (en) | Process for preparing a 7-aminocephalosporanic acid compound | |
EP0074095B1 (en) | Process for preparation of aspartylphenylalanine alkyl esters | |
JPS6057837B2 (en) | Method for producing cephalosporin compounds | |
JP3525190B2 (en) | Strain producing ε-poly-L-lysine in remarkable quantity and method for producing ε-poly-L-lysine using the same | |
EP0193608B1 (en) | Gif-2 and its preparation | |
US3975235A (en) | Process for the production of cephamycin type antibiotic substances | |
JPS61176531A (en) | Novel substance kt5556 and preparation thereof | |
EP0102529B1 (en) | Process for preparation of aspartylphenylalanine alkyl esters | |
JPS6144474B2 (en) | ||
JPS60995B2 (en) | New method for producing 7-amino-cephalosporanic acid and its derivatives | |
JPH0740951B2 (en) | Method for producing hydroxide of nitrogen-containing heterocyclic compound by microorganism | |
JPS5920359B2 (en) | Production method of polylysine | |
HU197944B (en) | Process for producing chanoclavine | |
JPH01104194A (en) | Production of d-(-)-tartaric acid | |
JPH04304894A (en) | Production of hydroxide of picolinic acid or pyrazinic acid by microorganism | |
JPS5831995A (en) | Preparation of l-serine | |
JPS6024198A (en) | Production of 12-keto-3alpha,7alpha-dihydroxycholanic acid | |
JPH07327690A (en) | Production of indigo | |
JPS62210996A (en) | Production of antibiotic substance emimycin | |
JPS581918B2 (en) | 3- Fuxocanethiomethylcephalosporin noseiho | |
JPH01309691A (en) | Production of d-alanine | |
JPH0588118B2 (en) | ||
JPH0360838B2 (en) | ||
HU198099B (en) | Process for producing festuclavine | |
JPS5871886A (en) | Monomethylamine oxidase and its preparation |